Melatonin Dosage FAQ: How Much to Take, When to Take It, and What Side Effects to Expect

Quick-Reference: Key Melatonin Numbers at a Glance

What Is Melatonin and How Does It Signal Sleep?

Melatonin is a hormone produced in the pineal gland, a small structure at the center of the brain. Its release is governed by the suprachiasmatic nucleus (SCN) — the brain's master circadian clock — which responds to light and darkness. As the evening darkens, the SCN signals the pineal gland to begin releasing melatonin into the bloodstream. Levels typically peak in the middle of the night and fall before dawn.

Melatonin acts on two receptor types, MT1 and MT2, in the brain and body. This interaction does not knock you out the way a sedative does. Instead, as Johns Hopkins sleep expert Luis Buenaver describes it, melatonin puts you into a state of quiet wakefulness that helps promote sleep — it is a circadian signal, not a sleeping pill.

This distinction matters enormously for dosing and timing. Because melatonin is a signal rather than a sedative, the amount needed to trigger the biological response is small — far smaller than what most supplements deliver. And because its job is to shift the circadian clock, when you take it is at least as important as how much you take.

Melatonin is synthesized from tryptophan via serotonin, and roughly 90% is metabolized in the liver by the enzyme CYP1A2. This metabolic pathway is why certain medications — particularly fluvoxamine, a CYP1A2 inhibitor — can dramatically raise melatonin blood levels and why drug interactions matter more with melatonin than many people assume.

What Dose of Melatonin Should Adults Start With?

The physiological amount of melatonin the pineal gland releases naturally is approximately 0.1–0.3 mg. Most adults find that a supplemental dose of 0.5–1 mg is sufficient to produce a measurable sleep-promoting effect. Johns Hopkins recommends starting at 1–3 mg, taken two hours before bedtime, and explicitly frames this as a "less is more" situation.

A 2024 systematic review and dose-response meta-analysis of 26 randomized controlled trials found that melatonin's effect on reducing sleep onset latency and increasing total sleep time gradually increases up to approximately 4 mg per day, after which no additional benefit is observed. The same analysis found that studies showing no added benefit above 10 mg align with this ceiling effect.

University of Colorado Anschutz pharmacist Luke Orth confirms: studies have shown no added benefit at doses exceeding 10 mg in any patient. The ceiling is not at 10 mg because 10 mg is optimal — it is because the receptors are already saturated at much lower doses.

Why Do Store Shelves Carry 5–10 mg If Lower Doses Work?

The short answer is regulatory: melatonin is classified as a dietary supplement under the Dietary Supplement Health and Education Act of 1994 (DSHEA). This means manufacturers are not required to demonstrate efficacy, establish an optimal dose, or verify dosage accuracy before selling a product. There is no regulatory ceiling on the dose a supplement manufacturer can put in a capsule or gummy.

Higher-dose products also reflect a common consumer assumption that more is more effective — a logic that applies to many medications but breaks down for circadian signaling hormones. Once the MT1 and MT2 receptors are activated, additional melatonin does not produce a proportionally stronger sleep effect; it primarily increases the duration of elevated blood levels and the risk of next-day grogginess.

When Is the Best Time to Take Melatonin?

The most common advice — "take it 30 minutes before bed" — is not wrong, but it is incomplete, and for circadian uses it may be suboptimal.

The 2024 dose-response meta-analysis found that advancing the timing to 3 hours before the desired bedtime, compared to the common 30-minute-before protocol, produced meaningfully better results for sleep onset latency. This makes mechanistic sense: melatonin's primary job is to shift the circadian clock, and the circadian system responds more readily to a signal that arrives well before the intended sleep window, not immediately at bedtime.

UC Davis Health recommends taking melatonin three to four hours before the desired sleep time when the goal is to shift sleep timing — for example, if you want to be asleep by 11 PM, take melatonin between 7 and 8 PM. This is the circadian-signaling use case.

The 30–45 minute window is appropriate for a different use case: when you want the mild sedative or hypnotic effect of melatonin — for instance, on a long overnight flight where you are trying to sleep at an unusual time, not to shift your clock long-term.

Jet Lag: Does the Timing Protocol Change?

For jet lag, the protocol differs from general sleep-onset use. The goal is not to improve sleep at home — it is to accelerate your body's adjustment to a new time zone. This means taking melatonin at the destination's bedtime, not your home bedtime.

Johns Hopkins recommends starting melatonin a few days before travel, taking it two hours before your bedtime at the destination. This approach helps prime the circadian system before you arrive.

• Eastward travel (e.g., New York to London): Requires advancing the clock — generally harder to adjust to. Melatonin taken at destination bedtime can help signal an earlier sleep phase.
• Westward travel (e.g., London to New York): Requires delaying the clock — generally easier to adjust to. Melatonin is less critical but can still help with sleep onset at the new local bedtime.
• Shift work: Evidence is weaker here. Two 2014 research reviews found studies were generally small or inconclusive. Melatonin may help some shift workers with daytime sleep, but the effect is modest and not well-established.

What Are the Common Side Effects of Melatonin?

Melatonin is generally well-tolerated at recommended doses, but side effects do occur — particularly at the higher doses found in most commercial products. They are typically mild and dose-dependent.

• Headache — one of the most commonly reported effects, particularly at higher doses.
• Dizziness — may occur shortly after taking a dose, especially in older adults.
• Daytime drowsiness or next-day grogginess — more likely at higher doses or with extended-release formulations; older adults are at elevated risk due to slower melatonin clearance.
• Vivid or unusual dreams — reported by some users, particularly at doses above 3 mg.
• Nausea — less common; more likely on an empty stomach or at high doses.
• Irritability or mood changes — occasionally reported, particularly with high-dose or prolonged use.

Who Should Avoid Melatonin or Use Extra Caution?

Several populations face meaningfully higher risks with melatonin and should either avoid it or consult a healthcare provider before use.

Drug interactions are a separate and significant concern. Melatonin is metabolized primarily by CYP1A2, and any medication that affects this enzyme or that shares a sedative or blood-thinning mechanism can interact meaningfully.

Can You Trust the Dose Listed on the Label?

Label accuracy for melatonin supplements is a genuine clinical problem, not a minor technicality. Because melatonin is a dietary supplement under DSHEA, manufacturers are not required to verify that the dose in the bottle matches what is printed on the label before selling the product.

A 2023 study published in JAMA analyzed 25 over-the-counter melatonin gummies and found that 22 of them — 88% — were inaccurately labeled. Actual melatonin content ranged from 74% to 347% of the declared amount. Some products contained significantly less than labeled; others contained more than three times the stated dose.

A separate analysis by FDA researchers of 110 melatonin supplements purchased in 2023, focusing on products marketed for children, found doses ranging from 0% to 667% of the label claim. This is the largest US analysis of melatonin products to date. The underlying peer-reviewed study was published in Drug Testing and Analysis in October 2024.

An earlier 2017 study in the Journal of Clinical Sleep Medicine found that melatonin content failed to meet a 10% margin of the label claim in more than 71% of supplements tested, with actual content ranging from 83% less to 478% more than declared. The same study detected serotonin — a more strictly controlled substance — in 26% of tested supplements.

Is It Safe to Take Melatonin Every Night?

Short-term use of melatonin — up to approximately six months in adults — appears generally safe based on available clinical trial data. Melatonin does not produce physical dependence or tolerance in the way that sedative-hypnotic medications do; stopping it does not cause withdrawal symptoms.

Beyond six months, the safety picture is less clear. Long-term studies are lacking, and the effects of sustained exogenous melatonin on the body's own production, hormonal regulation, and cardiovascular health have not been adequately characterized in large, long-duration trials.

A preliminary study presented at the American Heart Association's Scientific Sessions in 2025 examined five-year health records for more than 130,000 adults with insomnia and found that those with long-term melatonin use (12 or more months) had approximately 90% higher incidence of heart failure compared to matched non-users. This finding has attracted attention, but it must be interpreted carefully.

Does Melatonin Treat Chronic Insomnia?

This is one of the most important questions on this page, because the answer is often the opposite of what people expect.

The American Academy of Sleep Medicine's clinical practice guidelines state that clinicians should not use melatonin for the treatment of chronic insomnia disorder in adults. The National Center for Complementary and Integrative Health (NCCIH) and the American College of Physicians (ACP) both note that there is insufficient strong evidence on melatonin's effectiveness or safety for chronic insomnia to support its use.

Melatonin's evidence base is primarily in circadian rhythm disruption — jet lag, delayed sleep phase syndrome, and (with weaker evidence) shift work. Chronic insomnia is a different condition with different mechanisms, and melatonin does not address the hyperarousal, conditioned wakefulness, and sleep-related anxiety that drive most chronic insomnia.

Is Melatonin a Drug or a Dietary Supplement?

In the United States, melatonin is classified as a dietary supplement under the Dietary Supplement Health and Education Act of 1994 (DSHEA). This classification has significant practical consequences:

• No pre-market approval is required. Manufacturers do not need to demonstrate that a product is effective or that the dose on the label is accurate before selling it.
• No standardized dosage has been established by a regulatory body. The doses on store shelves reflect manufacturer decisions, not FDA-approved therapeutic ranges.
• Post-market surveillance is the primary oversight mechanism. The FDA can act after a product has been sold if it is found to be unsafe, but not before.

The international contrast is striking. In the European Union, Australia, and Japan, melatonin is regulated as a prescription drug. This means doses are controlled, efficacy must be demonstrated, and label accuracy is subject to regulatory oversight. The wide availability of high-dose melatonin in the US is a direct consequence of the DSHEA classification, not a reflection of clinical consensus about optimal dosing.

When Should You See a Doctor About Sleep?

Melatonin is a reasonable short-term tool for specific, well-defined situations — jet lag, adjusting a delayed sleep phase, or managing occasional sleep disruption. It is not a substitute for clinical evaluation when sleep problems are persistent, severe, or affecting your daily functioning.

Seek evaluation from a healthcare provider if any of the following apply:

• Sleep problems have persisted for more than a few weeks despite reasonable sleep hygiene practices.
• You are experiencing insomnia — difficulty falling asleep, staying asleep, or waking too early — that is affecting your mood, concentration, or daily functioning.
• You are relying on melatonin every night and feel unable to sleep without it.
• You are in any of the high-caution populations listed above — older adults, pregnant individuals, people with autoimmune disorders, seizure disorders, or depression.
• You take any of the medications listed in the drug interaction table, particularly anticoagulants, anticonvulsants, immunosuppressants, or fluvoxamine.
• You suspect you may have a sleep disorder such as sleep apnea, restless legs syndrome, or a circadian rhythm disorder — conditions that melatonin does not treat and that require proper diagnosis.